Kymera Therapeutic

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYMR and other ETFs, options, and stocks.

About KYMR

Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics. 

CEO
Nello Mainolfi
CEONello Mainolfi
Employees
141
Employees141
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2015
Founded2015
Employees
141
Employees141

KYMR Key Statistics

Market cap
1.55B
Market cap1.55B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
449.18K
Average volume449.18K
High today
$28.32
High today$28.32
Low today
$27.24
Low today$27.24
Open price
$27.40
Open price$27.40
Volume
303.65K
Volume303.65K
52 Week high
$66.45
52 Week high$66.45
52 Week low
$13.15
52 Week low$13.15

Analyst ratings

76%

of 17 ratings
Buy
76.5%
Hold
23.5%
Sell
0%

KYMR Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.